Thyroid Peroxidase (TPO) Antibodies
Thyroid peroxidase (TPO) is a large glycoprotein expressed only on the apical surface of thyrocytes (cells of the thyroid gland follicle). TPO is a critical enzyme involved in the multistep procedure of thyroid hormone (T3 and T4) synthesis, by iodinating thyroglobulin to form iodinated thyroglobulin which is stored in thyroid follicles in the form of colloid. T3 and T4 synthesis is stimulated by thyroid-stimulating hormone (TSH) which has the effects of stimulating production of thyroid follicle lining cells and proteolyzing iodinated thyroglobulin for release into the systemic circulation. TPO is well known to be the principle antigen against which antibodies are directed in autoimmune thyroid disease.
Elevated serum titer of antibody to TPO is found in several forms of thyroiditis. It was once believed this and other antibodies were the initiating events causing autoimmune thyroiditis, but it is now felt that the antibodies may not the initiating cause of autoimmune thyroid disease. High anti-TPO titers are found in up to 90% of patients with chronic Hashimoto’s thyroiditis. In Graves’ disease, 70% of patients have an elevated titer. Although the sensitivity of the procedure can be increased by simultaneously determining other thyroid antibodies (anti-Tg, TSH-receptor-antibody - TRAb), a negative finding does not rule out the possibility of an autoimmune disease. The magnitude of the antibody titer does not correlate with the clinical activity of the disease. Elevated titers can become negative after lengthy periods of illness or during remission. If antibody reappears following remission, then a relapse is probable.
- Diagnosis of autoimmune thyroid diseases including Hashimoto’s thyroiditis and Graves’ disease
- Differential diagnosis of hypothyroidism other than autoimmune origin
- Monitoring the treatment and disease management
- As an aid in diagnosis of Addison’s disease
- As an aid in the diagnosis of reproductive difficulties such as miscarriage, pre-eclampsia, premature delivery, and in-vitro fertilization failure
Increased in:
- Hashimoto’s thyroiditis
- Idiopathic myxedema
- Graves’ disease
- Addison’s disease
- Riedel’s thyroiditis
- Diabetes mellitus
Note: Low titers are present in 8 - 27% of normal individuals and patients with nonimmune thyroid disease and up to 14% of pregnant females.
0.0-35.0 IU/mL or Negative (Non-reactive)
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum (SST).
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 2 months
- Thyroid. 2007 Oct;17(10):939-48. [PMID: 17822378]
- Clin Exp Immunol. 1995 Aug;101(2):200-6. [PMID: 7544244]
- Immunogenetics. 2002 Jun;54(3):141-57. [PMID: 12073143]
- Autoimmunity. 2008 Feb;41(1):46-54. [PMID: 18176864]
- Ann Clin Biochem. 2006 May;43(Pt 3):173-83. [PMID: 1670475]
- Autoimmunity. 1991;8(4):335-43. [PMID: 1932517]
- Best Pract Res Clin Endocrinol Metab. 2005;19:1. [PMID: 15826919]